Attomarker Antibody Spectrum Test
Measuring the quality and quantity of antibodies
The COVID antibody spectrum test measures the quality and quantity of antibodies to spike protein from 13 different strains of the SARS-COV2 virus (COVID19).
Attomarker COVID Antibody Spectrum Test
The COVID Antibody Spectrum Test offers a detailed analysis of your immune response to COVID-19, including antibodies developed in response to both infection and vaccination. This test is provided using Attomarker’s advanced microfluidic technology, and is designed to assess both the quality and quantity of antibodies against the spike protein of 13 different SARS-CoV-2 variants.
Not a diagnostic test
Please Note: This test is not used to diagnose active COVID-19 infection. It indicates how the body has responded to previous exposure or infection.
While results are scientifically valuable, this test remains in the research phase and is not yet validated for making treatment decisions. Dr Kane is working with Prof Andrew Shaw a the University of Exeter to further research in this field and understand how this test can determine who would benefit from monoclonal antibody treatment as part of a clinical trial. Monoclonal antibodies are not currently available in the UK.
What does it measure?
- Antibodies against multiple COVID-19 strains, including early and recent variants.
- The strength of your immune response over time.
- How well your body may have responded to prior infection or vaccination.
For more information about the test you can watch this Livestream session below with Prof Andrew Shaw